Pentraxin 3, a novel cardiovascular biomarker, is expressed in aortic specimens of patients with coronary artery disease with and without rheumatoid arthritis

Cardiovascular Pathology

Volumn 22, Issue 5, 2013, Pages 324-331

  Hollan, Ivana ^a,b   Nebuloni, Manuela ^c   Bottazzi, Barbara ^d   Mikkelsen, Knut ^b   Førre, Øystein T ^e   Almdahl, Sven Martin ^f   Mantovani, Alberto ^d,g   Fagerland, Morten Wang ^h   Aukrust, Pål ⁱ   Meroni, Pier Luigi ^g  

^a Feiring Heart Clinic   (Norway)

^b Hospital for Rheumatic Diseases   (Norway)

^c UNIVERSITY OF MILAN   (Italy)

^d HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^e UNIVERSITY OF OSLO   (Norway)

^f UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^g UNIVERSITY OF MILAN   (Italy)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Atherosclerosis; Inflammation; Pentraxin 3; Rheumatoid arthritis

Indexed keywords

PENTRAXIN 3;

ADULT; AGED; AORTA; ARTICLE; BLOOD VESSEL BIOPSY; CARDIOVASCULAR INFLAMMATION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; FIBROSIS; HUMAN; HUMAN TISSUE; INTERNAL MAMMARY ARTERY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ATHEROSCLEROSIS; INFLAMMATION; PENTRAXIN 3; RHEUMATOID ARTHRITIS;

ADVENTITIA; AGED; AORTA; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MALE; MIDDLE AGED; SERUM AMYLOID P-COMPONENT; T-LYMPHOCYTES;

EID: 84884166977     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2013.01.007     Document Type: Article

References (28)

1. I Hollan, H Scott, K Saatvedt, R Prayson, K Mikkelsen, and HC Nossent Inflammatory rheumatic disease and smoking are predictors of aortic inflammation: a controlled study of biopsy specimens obtained at coronary artery surgery Arthritis Rheum 56 6 2007 2072 2079
2. I Hollan, R Prayson, K Saatvedt, SM Almdahl, HC Nossent, and K Mikkelsen Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients Circ J 72 12 2008 1986 1992
3. B Bottazzi, A Doni, C Garlanda, and A Mantovani An integrated view of humoral innate immunity: pentraxins as a paradigm Annu Rev Immunol 28 2010 157 183
4. R Latini, AP Maggioni, G Peri, L Gonzini, D Lucci, and P Mocarelli Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction Circulation 110 16 2004 2349 2354
5. NS Jenny, AM Arnold, LH Kuller, RP Tracy, and BM Psaty Associations of pentraxin 3 with cardiovascular disease and all-cause death: the Cardiovascular Health Study Arterioscler Thromb Vasc Biol 29 4 2009 594 599
6. N Kotooka, T Inoue, D Fujimatsu, T Morooka, S Hashimoto, and Y Hikichi Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening Atherosclerosis 197 1 2008 368 374
7. S Suzuki, Y Takeishi, T Niizeki, Y Koyama, T Kitahara, and T Sasaki Pentraxin 3, a new marker for vascular inflammation, predicts adverse clinical outcomes in patients with heart failure Am Heart J 155 1 2008 75 81
8. M Nebuloni, F Pasqualini, P Zerbi, E Lauri, A Mantovani, and L Vago PTX3 expression in the heart tissues of patients with myocardial infarction and infectious myocarditis Cardiovasc Pathol 2010
9. K Inoue, A Sugiyama, PC Reid, Y Ito, K Miyauchi, and S Mukai Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris Arterioscler Thromb Vasc Biol 27 1 2007 161 167
10. F Fazzini, G Peri, A Doni, G Dell'Antonio, CE Dal, and E Bozzolo PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation Arthritis Rheum 44 12 2001 2841 2850
11. GD Norata, P Marchesi, VK Pulakazhi Venu, F Pasqualini, A Anselmo, and F Moalli Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis Circulation 120 8 2009 699 708
12. M Salio, S Chimenti, AN De, F Molla, V Maina, and M Nebuloni Cardioprotective function of the long pentraxin PTX3 in acute myocardial infarction Circulation 117 8 2008 1055 1064
13. I Hollan, B Bottazzi, I Cuccovillo, OT Forre, K Mikkelsen, and K Saatvedt Increased levels of serum pentraxin 3, a novel cardiovascular biomarker, in patients with inflammatory rheumatic disease Arthritis Care Res (Hoboken) 62 3 2010 378 385
14. L Dagna, F Salvo, M Tiraboschi, EP Bozzolo, S Franchini, and C Doglioni Pentraxin-3 as a marker of disease activity in Takayasu arteritis Ann Intern Med 155 7 2011 425 433
15. M Baldini, N Maugeri, GA Ramirez, C Giacomassi, A Castiglioni, and S Prieto-Gonzalez Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia Arthritis Rheum 64 3 2012 854 865
16. MS Rolph, S Zimmer, B Bottazzi, C Garlanda, A Mantovani, and GK Hansson Production of the long pentraxin PTX3 in advanced atherosclerotic plaques Arterioscler Thromb Vasc Biol 22 5 2002 e10 e14
17. A Savchenko, M Imamura, R Ohashi, S Jiang, T Kawasaki, and G Hasegawa Expression of pentraxin 3 (PTX3) in human atherosclerotic lesions J Pathol 215 1 2008 48 55
18. S Lydersen, MW Fagerland, and P Laake Recommended tests for association in 2 x 2 tables Stat Med 28 7 2009 1159 1175
19. MW Fagerland, and L Sandvik Performance of five two-sample location tests for skewed distributions with unequal variances Contemp Clin Trials 30 5 2009 490 496
20. AC Langheinrich, M Kampschulte, T Buch, and RM Bohle Vasa vasorum and atherosclerosis - quid novi? Thromb Haemost 97 6 2007 873 879
21. D Vela, LM Buja, M Madjid, A Burke, M Naghavi, and JT Willerson The role of periadventitial fat in atherosclerosis Arch Pathol Lab Med 131 3 2007 481 487
22. M Klouche, G Peri, C Knabbe, HH Eckstein, FX Schmid, and G Schmitz Modified atherogenic lipoproteins induce expression of pentraxin-3 by human vascular smooth muscle cells Atherosclerosis 175 2 2004 221 228
23. GD Norata, P Marchesi, A Pirillo, P Uboldi, G Chiesa, and V Maina Long pentraxin 3, a key component of innate immunity, is modulated by high-density lipoproteins in endothelial cells Arterioscler Thromb Vasc Biol 28 5 2008 925 931
24. E Napoleone, SA di, G Peri, A Mantovani, GG de, and MB Donati The long pentraxin PTX3 up-regulates tissue factor in activated monocytes: another link between inflammation and clotting activation J Leukoc Biol 76 1 2004 203 209
25. DG Souza, AC Soares, V Pinho, H Torloni, LF Reis, and MM Teixeira Increased mortality and inflammation in tumor necrosis factor-stimulated gene-14 transgenic mice after ischemia and reperfusion injury Am J Pathol 160 5 2002 1755 1765
26. L Deban, RC Russo, M Sironi, F Moalli, M Scanziani, and V Zambelli Regulation of leukocyte recruitment by the long pentraxin PTX3 Nat Immunol 11 4 2010 328 334
27. A Salustri, C Garlanda, E Hirsch, AM De, A Maccagno, and B Bottazzi PTX3 plays a key role in the organization of the cumulus oophorus extracellular matrix and in in vivo fertilization Development 131 7 2004 1577 1586
28. AP van Rossum, HH Pas, F Fazzini, MG Huitema, PC Limburg, and MF Jonkman Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis Arthritis Rheum 54 3 2006 986 991